[clicca qui per la versione in italiano]

click here for a large picture
It is commonly believed that only big Multinationals are able to face the economic, scientific, technologic and managerial challenges posed by the synthesis and development of a new drug. Yet, size is not everything. What really matters is the ability to make the most out of specific attitudes.
Angelini has concentrated on a type di research on specific and limited areas, harvesting the remarkable flexibility typical to medium size Italian Companies.

Thus, Angelini is a paradigm of how a relatively ìsmallî domestic company, making the most out of flexibility and creativity, can successfully contribute to the development of a sector strategic to the national economy.